Loading...
Safety assessment of excipients (SAFE) for orally inhaled drug products.
Metz, Julia K Scharnowske, Lara Hans, Fabian Schnur, Sabrina Knoth, Katharina Zimmer, Horst Limberger, Markus Groß, Henrik Lehr, Claus Michael Hittinger, Marius
Metz, Julia K
Scharnowske, Lara
Hans, Fabian
Schnur, Sabrina
Knoth, Katharina
Zimmer, Horst
Limberger, Markus
Groß, Henrik
Lehr, Claus Michael
Hittinger, Marius
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2020-01-29
Submitted date
Files
Loading...
Open Access publication
Adobe PDF, 748.24 KB
Other Titles
Abstract
The development of new orally inhaled drug products requires the demonstration of safety which must be proven in animal experiments. New in vitro methods may replace, or at least reduce, these animal experiments provided they are able to correctly predict the safety or eventual toxicity in humans. However, the challenge is to link human in vitro data to human in vivo data. We here present a new approach to the safety assessment of excipients (SAFE) for pulmonary drug delivery. The SAFE model is based on a dose response curve of 23 excipients tested on the human pulmonary epithelial cell lines A549 and Calu-3. The resulting in vitro IC50 values were correlated with the FDA-approved concentration in pharmaceutical products for either pulmonary (if available) or parenteral administration. Setting a threshold of 0.1% (1 mg/mL) for either value yielded four safety classes, allowed to link IC50 data as measured on human cell cultures in vitro with the concentrations of the same compounds in FDA-approved drug products. The necessary in vitro data for novel excipients can be easily generated while the SAFE approach allows putting them in the context for eventual use in human pulmonary drug products. Excipients, that are most likely not safe for use in humans, can be early excluded from further pharmaceutical development. The SAFE approach helps thus to avoid unnecessary animal experiments.
Citation
ALTEX. 2020 Jan 29. doi: 10.14573/altex.1910231.
Publisher
Journal
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
1868-596X
EISSN
ISBN
ISMN
Gov't Doc #
Sponsors
License
Attribution-NonCommercial-ShareAlike 4.0 International